One documented 9-week protocol showed deadlift and squat performance holding steady throughout, though this was at lower doses (0.5-1mg)
Talk to a qualified clinician before considering use
The primary antibodies used were anti- VEGF-A (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti- VEGFR1 (Cell Signaling Technology, Berkeley, CA, USA), anti- pVEGFR1 (Cell Signaling Technology, Berkeley, CA, USA), anti- AKT (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti- pAKT (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti- ERK (Cell Signaling Technology, Berkeley, CA, USA), anti- pERK (Cell SignalingT echnology, Berkeley, CA, USA), anti- p38 (Cell Signaling Technology, Berkeley, CA, USA), anti- p-p38 (Cell Signaling Technology, Berkeley, CA, USA), anti- eNOS (Proteintech, Chicago, IL, USA), anti- p-eNOS (Proteintech, Chicago, IL, USA), anti- CHOP (Cell Signaling Technology, Berkeley, CA, USA) and anti- -actin (Cell Signaling Technology, Berkeley, CA, USA)
Weeks 512: Reduced portions feel natural, steady weight loss begins
Every body responds to treatment differently, but most patients begin to notice a difference in their energy levels and appetite within the first few weeks